Difference between revisions of "About-cancer/treatment/drugs/tocilizumab"
(Created page with "== 标题文字 == This page contains brief information about tocilizumab and a collection of links to more information about the use of this drug, research results, and ongo...") |
(Marked this version for translation) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | == 标题文字 == | + | <languages/> |
| + | <translate> | ||
| + | == 标题文字 == <!--T:1--> | ||
| + | <!--T:2--> | ||
This page contains brief information about tocilizumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about tocilizumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
Actemra | Actemra | ||
| + | <!--T:5--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:6--> | ||
Yes | Yes | ||
| + | <!--T:7--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:8--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:9--> | ||
Tocilizumab is approved to treat: | Tocilizumab is approved to treat: | ||
| + | <!--T:10--> | ||
* release syndrome (CRS) that is severe or life-threatening. It is used in adults and children aged 2 years and older who have CRS caused by chimeric antigen receptor (CAR) T-cell therapy. | * release syndrome (CRS) that is severe or life-threatening. It is used in adults and children aged 2 years and older who have CRS caused by chimeric antigen receptor (CAR) T-cell therapy. | ||
Tocilizumab is also being studied in the treatment of other conditions. | Tocilizumab is also being studied in the treatment of other conditions. | ||
| + | <!--T:11--> | ||
'''More About Tocilizumab''' | '''More About Tocilizumab''' | ||
| + | <!--T:12--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:13--> | ||
MedlinePlus Information on Tocilizumab - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Tocilizumab - A lay language summary of important information about this drug that may include the following: | ||
| + | <!--T:14--> | ||
*warnings about this drug, | *warnings about this drug, | ||
| + | <!--T:15--> | ||
*what this drug is used for and how it is used, | *what this drug is used for and how it is used, | ||
| + | <!--T:16--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
| + | <!--T:17--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
| + | <!--T:18--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
| + | <!--T:19--> | ||
*possible side effects. | *possible side effects. | ||
| + | <!--T:20--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
| + | <!--T:21--> | ||
'''Research Results and Related Resources''' | '''Research Results and Related Resources''' | ||
| + | <!--T:22--> | ||
Monoclonal Antibodies | Monoclonal Antibodies | ||
| + | <!--T:23--> | ||
CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers | CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers | ||
| + | <!--T:24--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:25--> | ||
Find Clinical Trials for Tocilizumab - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Tocilizumab - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:26--> | ||
'''Important''': The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important''': The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
| + | </translate> | ||
Latest revision as of 21:41, 29 October 2019
标题文字
This page contains brief information about tocilizumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Actemra
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Tocilizumab is approved to treat:
- release syndrome (CRS) that is severe or life-threatening. It is used in adults and children aged 2 years and older who have CRS caused by chimeric antigen receptor (CAR) T-cell therapy.
Tocilizumab is also being studied in the treatment of other conditions.
More About Tocilizumab
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Tocilizumab - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Monoclonal Antibodies
CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers
Clinical Trials Accepting Patients
Find Clinical Trials for Tocilizumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
